| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 451,800 | 450,700 | 408,900 | 403,700 | | Cost of Revenue | 135,100 | 250,400 |
-
| 493,300 | | | Gross Profit | 316,700 | 200,300 | 408,900 | (89,600) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 124,300 | (5,700) | 232,600 | (246,400) | | Non Recurring | 3,700 | 3,100 | 11,800 | 200 | | Others | 16,200 | 15,700 | 15,600 | 31,200 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 172,500 | 187,200 | 148,900 | 125,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,700 | (14,700) | 4,200 | (44,800) | | Earnings Before Interest And Taxes | 153,300 | 172,500 | 153,100 | 80,600 | | Interest Expense | (9,400) | (2,100) | 11,500 | (43,700) | | Income Before Tax | 162,700 | 174,600 | 141,600 | 124,300 | | Income Tax Expense | 61,000 | 63,600 | 50,500 | 35,600 | | Minority Interest |
-
| 900 | (900) |
-
| | | | Net Income From Continuing Ops | 98,000 | 111,900 | 90,200 | 88,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 98,000 | 111,900 | 90,200 | 88,700 | | Preferred Stock And Other Adjustments | 2,600 | (2,600) |
-
|
-
| | | Net Income Applicable To Common Shares | $100,600 | $109,300 | $90,200 | $88,700 |
|
0.01% Nasdaq 
0.22%
Income Statement
